France · Source-listed medicine information

France / CIS 63363997

REVITALOSE SANS SUCRE, solution buvable édulcorée au sorbitol

solution et solution buvable · orale

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution et solution buvable
Routeorale
Ingredient entries7
CountryFrance

Product identity

At a glance

Authorisation holder
PIERRE FABRE MEDICAMENT
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 63363997

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for REVITALOSE SANS SUCRE, solution buvable édulcorée au sorbitol
IngredientStrength / referenceSource role
LEUCINEsolution A0,025 g5 mlSAGroup 2
PHÉNYLALANINEsolution A0,010 g5 mlSAGroup 4
VALINEsolution A0,010 g5 mlSAGroup 5
DL-LYSINE (MONOCHLORHYDRATE DE)solution A0,200 g5 mlSAGroup 3
MAGNÉSIUM (ASPARTATE DE) DIHYDRATÉsolution A0,200 g5 mlSAGroup 1
ACIDE ASCORBIQUEsolution B1,000 g5 mlFTGroup 13
SODIUM (ASCORBATE DE)solution B1,125 g5 mlSAGroup 13

Pack references

Presentations (1)

14 ampoule(s) en verre brun de 5 ml - 14 ampoule(s) en verre brun de 5 ml

CIP13 3400933573003

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 63363997 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →